210 related articles for article (PubMed ID: 32671950)
1. Polypharmacy and potential drug-drug interactions for people with HIV in the UK from the Climate-HIV database.
Okoli C; Schwenk A; Radford M; Myland M; Taylor S; Darley A; Barnes J; Fox A; Grimson F; Reeves I; Munshi S; Croucher A; Boxall N; Benn P; Paice A; van Wyk J; Khoo S
HIV Med; 2020 Sep; 21(8):471-480. PubMed ID: 32671950
[TBL] [Abstract][Full Text] [Related]
2. Polypharmacy and risk of antiretroviral drug interactions among the aging HIV-infected population.
Holtzman C; Armon C; Tedaldi E; Chmiel JS; Buchacz K; Wood K; Brooks JT;
J Gen Intern Med; 2013 Oct; 28(10):1302-10. PubMed ID: 23605401
[TBL] [Abstract][Full Text] [Related]
3. Comedication prescription patterns and potential for drug-drug interactions with antiretroviral therapy in people living with human immunodeficiency virus type 1 infection in Germany.
Lopes S; O'Day K; Meyer K; Van Stiphout J; Punekar Y; Radford M; Haas JS
Pharmacoepidemiol Drug Saf; 2020 Mar; 29(3):270-278. PubMed ID: 31950545
[TBL] [Abstract][Full Text] [Related]
4. Polypharmacy and Drug-Drug Interactions in People Living With Human Immunodeficiency Virus in the Region of Madrid, Spain: A Population-Based Study.
López-Centeno B; Badenes-Olmedo C; Mataix-Sanjuan Á; McAllister K; Bellón JM; Gibbons S; Balsalobre P; Pérez-Latorre L; Benedí J; Marzolini C; Aranguren-Oyarzábal A; Khoo S; Calvo-Alcántara MJ; Berenguer J
Clin Infect Dis; 2020 Jul; 71(2):353-362. PubMed ID: 31428770
[TBL] [Abstract][Full Text] [Related]
5. Use of comedications and potential drug-drug interactions in people living with HIV in China.
Chen R; Chen J; Tang Q; Meng Z; Luo L; Zhang W; Deng A; Zhang L; Wang J; Qi T; Zhang R; Shen Y; Liu L; Steinhart C; Lu H
J Infect Chemother; 2020 Jul; 26(7):722-728. PubMed ID: 32354599
[TBL] [Abstract][Full Text] [Related]
6. Association of age with polypharmacy and risk of drug interactions with antiretroviral medications in HIV-positive patients.
Tseng A; Szadkowski L; Walmsley S; Salit I; Raboud J
Ann Pharmacother; 2013 Nov; 47(11):1429-39. PubMed ID: 24285760
[TBL] [Abstract][Full Text] [Related]
7. Burden of Exposure to Potential Interactions Between Antiretroviral and Non-Antiretroviral Medications in a Population of HIV-Positive Patients Aged 50 Years or Older.
Ranzani A; Oreni L; Agrò M; van den Bogaart L; Milazzo L; Giacomelli A; Cattaneo D; Gervasoni C; Ridolfo AL
J Acquir Immune Defic Syndr; 2018 Jun; 78(2):193-201. PubMed ID: 29767640
[TBL] [Abstract][Full Text] [Related]
8. Polypharmacy and drug-drug interactions in older and younger people living with HIV: the POPPY study.
Halloran MO; Boyle C; Kehoe B; Bagkeris E; Mallon P; Post FA; Vera J; Williams I; Anderson J; Winston A; Sachikonye M; Sabin C; Boffito M
Antivir Ther; 2019; 24(3):193-201. PubMed ID: 30700636
[TBL] [Abstract][Full Text] [Related]
9. Polypharmacy and potential drug-drug interactions among people living with HIV in the era of integrase strand transfer inhibitor-based antiretroviral therapy.
Peng AT; Huang SH; Lee HY; Wu PY; Kuo HY; Hung CC
Int J Antimicrob Agents; 2024 Feb; 63(2):107067. PubMed ID: 38141835
[TBL] [Abstract][Full Text] [Related]
10. Recognition of possible risk factors for clinically significant drug-drug interactions among Indian people living with HIV receiving highly active antiretroviral therapy and concomitant medications.
Priyanka PSSL; Varma DM; Immadisetti K; Rajesh R; Vidyasagar S; Guddattu V
Int J Risk Saf Med; 2017; 29(1-2):25-55. PubMed ID: 28885219
[TBL] [Abstract][Full Text] [Related]
11. Co-medications and Drug-Drug Interactions in People Living with HIV in Turkey in the Era of Integrase Inhibitors.
Yeşilbağ Z; Şengül Eİ; Şenoğlu S; Aydın ÖA; Karaosmanoğlu HK
Curr HIV Res; 2020; 18(6):415-425. PubMed ID: 32787762
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of possible drug-drug interactions between antiretroviral agents in different age groups in a section of the private health care sector setting in South Africa.
Katende-Kyenda NL; Lubbe MS; Serfontein JH; Truter I
J Clin Pharm Ther; 2008 Aug; 33(4):393-400. PubMed ID: 18613857
[TBL] [Abstract][Full Text] [Related]
13. Comorbidities and the use of comedications in people living with HIV on antiretroviral therapy in Japan: a cross-sectional study using a hospital claims database.
Ruzicka DJ; Imai K; Takahashi K; Naito T
BMJ Open; 2018 Jun; 8(6):e019985. PubMed ID: 29903786
[TBL] [Abstract][Full Text] [Related]
14. The intersection of drug interactions and adverse reactions in contemporary antiretroviral therapy.
Nhean S; Tseng A; Back D
Curr Opin HIV AIDS; 2021 Nov; 16(6):292-302. PubMed ID: 34459470
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and type of drug-drug interactions involving ART in patients attending a specialist HIV outpatient clinic in Kampala, Uganda.
Seden K; Merry C; Hewson R; Siccardi M; Lamorde M; Byakika-Kibwika P; Laker E; Parkes-Ratanshi R; Back DJ; Khoo SH
J Antimicrob Chemother; 2015 Dec; 70(12):3317-22. PubMed ID: 26286575
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study.
Marzolini C; Elzi L; Gibbons S; Weber R; Fux C; Furrer H; Chave JP; Cavassini M; Bernasconi E; Calmy A; Vernazza P; Khoo S; Ledergerber B; Back D; Battegay M;
Antivir Ther; 2010; 15(3):413-23. PubMed ID: 20516560
[TBL] [Abstract][Full Text] [Related]
17. Drug-drug Interactions in Patients with HIV and Cancer in Sub-Saharan Africa.
Strope JD; Lochrin SE; Sissung TM; Kem R; Chandrasekaran P; Sharon E; Price DK; Uldrick TS; Yarchoan R; Figg WD
AIDS Rev; 2020 Oct; 23(1):13-27. PubMed ID: 33105469
[TBL] [Abstract][Full Text] [Related]
18. The Challenge of Potential Drug-Drug Interactions Among People Living With HIV on Antiretroviral Therapy: A Cross-Sectional Study in Selected Provinces in China.
Xia H; Gao L; Gong X; Zaongo SD; Zhang T; Wu H; Ma P; Huang X
Front Pharmacol; 2020; 11():800. PubMed ID: 32536872
[TBL] [Abstract][Full Text] [Related]
19. DeepARV: ensemble deep learning to predict drug-drug interaction of clinical relevance with antiretroviral therapy.
Pham T; Ghafoor M; Grañana-Castillo S; Marzolini C; Gibbons S; Khoo S; Chiong J; Wang D; Siccardi M
NPJ Syst Biol Appl; 2024 May; 10(1):48. PubMed ID: 38710671
[TBL] [Abstract][Full Text] [Related]
20. Ageing with HIV: do comorbidities and polymedication drive treatment optimization?
Cuzin L; Katlama C; Cotte L; Pugliese P; Cheret A; Bernaud C; Rey D; Poizot-Martin I; Chirouze C; Bani-Sadr F; Cabié A;
HIV Med; 2017 Jul; 18(6):395-401. PubMed ID: 28858437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
